FBXL17 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.388200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.074000E-01
Normal-vs-Stage2
2.678400E-01
Normal-vs-Stage3
4.703500E-02
Normal-vs-Stage4
8.252400E-01
Stage1-vs-Stage2
7.744500E-03
Stage1-vs-Stage3
3.069700E-02
Stage1-vs-Stage4
4.240200E-01
Stage2-vs-Stage3
1.324400E-01
Stage2-vs-Stage4
3.219600E-01
Stage3-vs-Stage4
1.780420E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.439600E-01
Normal-vs-AfricanAmerican
9.023600E-01
Normal-vs-Asian
8.296200E-02
Caucasian-vs-AfricanAmerican
5.127600E-01
Caucasian-vs-Asian
1.588610E-01
AfricanAmerican-vs-Asian
8.057800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.601200E-01
Normal-vs-Female
6.286400E-01
Male-vs-Female
6.978800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.813400E-01
Normal-vs-Age(41-60Yrs)
8.490800E-01
Normal-vs-Age(61-80Yrs)
4.104400E-01
Normal-vs-Age(81-100Yrs)
9.262400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.267600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.340400E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.644000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.491800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.514000E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.915000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.065640E-01
Normal-vs-Daily Drinker
2.190400E-01
Normal-vs-Weekly Drinker
1.677050E-01
Normal-vs-Occasional Drinker
9.701200E-01
Normal-vs-Social Drinker
9.177800E-01
Non Drinker-vs-Daily Drinker
9.819400E-01
Non Drinker-vs-Weekly Drinker
6.725800E-01
Non Drinker-vs-Occasional Drinker
1.408040E-01
Non Drinker-vs-Social Drinker
2.257800E-01
Daily Drinker-vs-Weekly Drinker
7.233600E-01
Daily Drinker-vs-Occasional Drinker
1.572550E-01
Daily Drinker-vs-Social Drinker
2.468800E-01
Weekly Drinker-vs-Occasional Drinker
1.175030E-01
Weekly Drinker-vs-Social Drinker
1.869170E-01
Occasional Drinker-vs-Social Drinker
8.147400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.503750E-01
Normal-vs-Grade 2
1.711820E-02
Normal-vs-Grade 3
1.406500E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.664400E-02
Grade 1-vs-Grade 3
1.103830E-01
Grade 1-vs-Grade 4
1.503750E-01
Grade 2-vs-Grade 3
7.035600E-01
Grade 2-vs-Grade 4
1.711820E-02
Grade 3-vs-Grade 4
1.406500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.536800E-01
Normal-vs-NonDiabetic
5.832400E-01
Diabetic-vs-NonDiabetic
2.151200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.283010E-01
Normal-vs-NoPancreatitis
5.585000E-01
Pancreatitis-vs-NoPancreatitis
1.684840E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.602800E-01
Normal-vs-N1
2.763400E-01
N0-vs-N1
9.650500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.753400E-01
Normal-vs-TP53-NonMutant
8.437200E-01
TP53-Mutant-vs-TP53-NonMutant
1.121120E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
